PLACCINE Trademark

Trademark Overview


On Wednesday, March 8, 2023, a trademark application was filed for PLACCINE with the United States Patent and Trademark Office. The USPTO has given the PLACCINE trademark a serial number of 97828639. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, July 23, 2024. This trademark is owned by Imunon, Inc.. The PLACCINE trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Development of platform technology, namely, cancer immunotherapy, infectious disease vaccines, and gene therapy platforms for manufacturing therapeutics and vaccines; Biological and biotechnology research; research and development in the pharmaceutical and biotechnology fields; scientific research and development with regard to the manufacture of pharmaceutical preparations; chemical and biological analysis; development of pharmaceutical preparations for treating cancer; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; scientific and technological research in the fields of genetics, immunotherapy, vaccination, and oncology
placcine

General Information


Serial Number97828639
Word MarkPLACCINE
Filing DateWednesday, March 8, 2023
Status688 - NOTICE OF ALLOWANCE - ISSUED
Status DateTuesday, July 23, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 28, 2024

Trademark Statements


Goods and ServicesDevelopment of platform technology, namely, cancer immunotherapy, infectious disease vaccines, and gene therapy platforms for manufacturing therapeutics and vaccines; Biological and biotechnology research; research and development in the pharmaceutical and biotechnology fields; scientific research and development with regard to the manufacture of pharmaceutical preparations; chemical and biological analysis; development of pharmaceutical preparations for treating cancer; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; scientific and technological research in the fields of genetics, immunotherapy, vaccination, and oncology

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, March 28, 2023
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameImunon, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressLawrenceville, NJ 08648

Party NameImunon, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressLawrenceville, NJ 08648

Trademark Events


Event DateEvent Description
Saturday, March 11, 2023NEW APPLICATION ENTERED
Tuesday, March 28, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, December 6, 2023ASSIGNED TO EXAMINER
Monday, December 18, 2023NON-FINAL ACTION WRITTEN
Monday, December 18, 2023NON-FINAL ACTION E-MAILED
Monday, December 18, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, March 18, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, March 18, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, March 18, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, April 22, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 8, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 28, 2024PUBLISHED FOR OPPOSITION
Tuesday, May 28, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 23, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT